Clinical Trial Detail

NCT ID NCT01428492
Title Ph 1b Study to Evaluate GSK2110183 in Combination With Bortezomib and Dexamethasone in Subjects With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlaxoSmithKline
Indications

multiple myeloma

Therapies

Afuresertib

Bortezomib

Dexamethasone

Age Groups: adult

No variant requirements are available.